Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

propranolol hydrochloride

View Patient Information
The hydrochloride form of propranolol, a synthetic beta-adrenergic receptor blocker with antianginal, antiarrhythmic, and antihypertensive properties. Propranolol competitively antagonizes beta-adrenergic receptors, thereby inhibiting beta-adrenergic reactions, such as vasodilation, and negative chronotropic and inotropic effects.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Hemangeol
Inderal
Chemical structure:2-propanol-1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy) hydrochloride
NSC code:91523
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search